The present invention relates to devices, systems, and methods for removing gases from medical devices, e.g., stent-grafts and their delivery systems, to reduce the risk of air embolism.
Endovascular aortic repair (EVAR) is a type of endovascular surgery used to treat pathology of the aorta. The most common EVAR treatment is of an abdominal aortic aneurysm, but many different types of aortic pathologies are treated by EVAR. When used to treat thoracic aortic disease, the procedure is then specifically termed TEVAR (thoracic endovascular aortic/aneurysm repair). The procedure involves placement of an expandable stent-graft within the aorta to treat the aortic disease without operating directly on the aorta. In 2003, EVAR surpassed open aortic surgery as the most common technique for repair of abdominal aortic aneurysm, and in 2010, EVAR accounted for 78% of all intact abdominal aortic aneurysm repair in the United States.
The procedure is carried out in a sterile environment under x-ray fluoroscopic guidance by a vascular surgeon, cardiac surgeon, interventional radiologist, general surgeon, or interventional cardiologist. The patient's femoral arteries are generally accessed percutaneously, e.g., with a surgical incision or direct puncture in the groin. Vascular sheaths are introduced into the patient's femoral arteries, through which one or more guide wires, catheters, and the stent-graft are introduced. The stent-graft acts as an artificial lumen for blood to flow through, thereby substantially isolating the aneurysm sac from direct blood flow and blood-pressure and thereby preventing further enlargement and rupture. The stent-graft is compressed into a catheter, introducer sheath, or other delivery system that allows the compressed stent-graft to be introduced from the femoral arteries to the intended place of deployment.
A stent-graft is typically an assembly of a fabric material and a metal frame or metal springs/stents and mounted on a catheter assembly. When introduced into the vasculature, stent-grafts are constrained to a smaller diameter to enable introduction by different techniques, such as a constraining sleeve or by loading into an introducer sheath. Stent-grafts, stents, and their catheter assemblies are typically produced, constrained, packed and, sterilized under room-air conditions. Consequently, spaces within a constraining sleeve or sheath that are not filled by the stent-graft or stent and/or the catheter assembly generally contain room air. For sterilization, the assemblies are packed in packaging, which is permeable for gas and are sterilized, e.g., using vacuum with ethyleneoxide-containing gas. The gas is removed by repeated vacuum and room air ventilation as a later step of the gas-sterilization process. Thus, when the product is delivered in its sterile packaging there is generally air present within the stent-graft assembly.
In the operating theatre, the stent-graft assemblies are unpacked from their packaging under sterile conditions. Air is partially removed from some stent-grafts and their catheter assemblies prior to introduction into the vasculature typically by flushing the sheath with isotonic solutions such as saline through flushing ports that are part of the catheter assemblies. Stent-grafts that are constrained using a sleeve, such as the Gore TAG and cTAG device, are typically introduced into the vasculature without flushing to remove the room-air from the assembly.
It is well recognized that deployment of stent-grafts in the thoracic aorta involves a significant risk for stroke. It has been reported to be as high as 10% and is a major drawback of TEVAR.
While retrospective studies have been done, the pathomechanism of stroke as a complication of TEVAR is not well known. Generally, the main source for strokes are thought to be embolism by particles from thrombotic and atherosclerotic material adherent to the aortic wall, which is released by manipulation during deployment by wires, catheters, sheaths and the stent graft. Air-embolism by release of trapped air from the stent-graft during TEVAR may be a significant source of such strokes despite flushing techniques; however, it has been difficult to detect such events since the trapped air is not visible on fluoroscopy and they may only first recognized after the patient has woken up.
The risk of air-embolism and stroke during open surgery is well known and preventive strategies have been employed, e.g., in open cardiac surgery and neuro-surgery. Preventive strategies to avoid the introduction of air within endovascular devices into the human body include extensive saline flushing to mechanically squeeze out the air, which is present in catheters, stents (uncovered metal stents), coils, and other devices prior to introduction of these devices into the patient's vasculature. Such flushing with saline generally works well in these applications as air may be removed almost completely and so such flushing is generally part of the instructions for use of these devices. To what extend air is actually removed from such devices and how much air remains and is introduced into the vasculature is not well studied.
With stent-grafts (prosthetic vascular grafts supported by metal stents), flushing with saline solution may not work well to remove air prior to introduction into the body. However, it is the method that is widely recommended and used today in most procedures. Because stent-grafts are combinations of stents with a fabric-covering, traditional mechanical flushing with saline may not work well because the fabric significantly hampers the ability to completely drive out the air. Also, factors like the degree of compression may influence the amount of “trapped air.”
Another factor is the presence of side-branches and other advanced tools in modern stent-grafts and their delivery-systems, which may create pockets where air may be compressed during flushing, but not squeezed out. The trapped air may then be released during intravascular deployment of the procedure but may not be visually recognized during the procedure since air is not visible under fluoroscopy, which is generally used for such procedures. The released air may become visible on postoperative CT-scans after EVAR for abdominal aortic aneurysms in the aneurysm-sac days after the procedure, e.g., as shown in
Trapped air may also be released when stent-grafts are deployed in segments of the aorta, which are close to brain-supplying arteries, the aortic trunk vessels, e.g., the innominate artery, left common carotid artery, and left subclavian artery. When such trapped air is released, there is a risk of air embolization into the brain. The same is true if these stent-grafts are released close to the coronary arteries, giving rise to a risk for air-embolization into the coronary arteries with a risk for myocardial infarction. Thus, insufficient removal of air from stent-grafts and/or their delivery systems before they are introduced into the vasculature may be a significant source of stroke during TEVAR.
Air is also known to be released from other medical devices used in neuroradiological procedures. For example, stents and coils and their delivery-assemblies, which are introduced in the arteries of the brain, may also contain air, which may potentially cause damage in the brain.
Accordingly, devices and methods that facilitate removing air or other gases from medical devices, particularly stent-grafts, stents, coils and their delivery systems, to reduce the risk of embolism would be useful.
The present invention is directed to devices and methods for removing gases from medical devices, e.g., e.g., stent-grafts and their delivery systems, to reduce the risk of air embolism. More particularly, the present invention is directed to systems and methods for flushing medical devices and/or for loading such devices into delivery systems without substantial exposure to air once flushed.
For example, the systems and methods herein may involve “de-airing” a sleeve-constrained stent-graft before the stent-graft is introduced into the human vasculature. De-airing is principally done by replacing trapped air by other gases or fluids, which are better tolerated and have a decreased risk of embolization. Typical flushing gases may include one or more of carbon dioxide, oxygen, argon, helium or other gases, which are better tolerated within the vasculature. Flushing liquids may include one or more of saline solutions, other isomolar solutions, degassed or partially degassed solutions or chemicals with a high solubility of respiratory gases, such as perfluorochemicals.
In accordance with one embodiment, a flushing device is provided that includes an elongate tubular member including a first end, a second end, and a chamber therein extending between the first and second ends; first and second ports spaced apart from one another along the tubular member and communicating with the chamber; and one or more sources of flushing fluid connectable to one or both of the first and second ports to create a flushing circuit delivering flushing fluid into the first port, through the chamber, and out the second port to remove air or other gases from the chamber.
In accordance with another embodiment, a flushing device is provided that includes an elongate tubular member including a first end, a second end, a central chamber therein extending between the first and second ends; first and second ports spaced apart from one another along the tubular member; first and second annular chambers at least partially surrounding the central chamber, the first annular chamber communicating with the first port and including a first opening communicating with the central chamber at the first end of the tubular member, the second annular chamber communicating with the second port and including a second opening communicating with the central chamber at the second end of the tubular; and one or more sources of flushing fluid connectable to one or both of the first and second ports to create a flushing circuit delivering flushing fluid into the first port, through the chamber, and out the second port to remove air or other gases from the chamber.
In accordance with yet another embodiment, a system is provided for flushing a medical device before introduction into a patient's body that includes an elongate tubular member including a first end, a second end, and a chamber therein extending between the first and second ends; an introducing assembly carrying a stent-graft received within the chamber; first and second ports spaced apart from one another along the tubular member and communicating with the chamber; and one or more sources of flushing fluid connectable to one or both of the first and second ports to create a flushing circuit delivering flushing fluid into the first port, through the chamber, and out the second port to remove air or other gases from the stent-graft.
In accordance with still another embodiment, a system is provided for flushing a medical device before introduction into a patient's body that includes an elongate tubular member including a first end, a second end, a central chamber therein extending between the first and second ends; an introducing assembly carrying a stent-graft received within the chamber; first and second ports spaced apart from one another along the tubular member; first and second annular chambers at least partially surrounding the central chamber, the first annular chamber communicating with the first port and including a first opening communicating with the central chamber at the first end of the tubular member, the second annular chamber communicating with the second port and including a second opening communicating with the central chamber at the second end of the tubular member; and one or more sources of flushing fluid connectable to one or both of the first and second ports to create a flushing circuit delivering flushing fluid into the first port, through the chamber, and out the second port to remove air or other gases from the chamber.
In accordance with yet another embodiment, a system is provided for flushing a medical device before introduction into a patient's body that includes an elongate tubular member including a first end, a second end, a chamber therein extending between the first and second ends, and first and second ports spaced apart from one another along the tubular member and communicating with the chamber; an introducing assembly carrying a stent-graft received within the chamber; and a flushing machine including one or more reservoirs and a circuit communicating with the first and second ports for selectively introducing one or more flushing fluids into the chamber to flush the introducing assembly and stent-graft and removing gases and excess flushing fluid from the chamber.
In accordance with another embodiment, a method is provided for removing gas from a stent-graft that includes providing a flushing device including a chamber extending between first and second ends thereof; introducing an introducing assembly carrying the stent-graft constrained within a sleeve into the chamber; and flushing the chamber with one or more flushing fluids.
Other aspects and features of the present invention will become apparent from consideration of the following description taken in conjunction with the accompanying drawings.
The drawings illustrate exemplary embodiments of the invention, in which:
Reducing the amount of air present in a stent-graft, stent, or other prosthesis and their delivery systems may reduce the incidents of stroke and/or other damage that may result from air embolism. In accordance with an exemplary embodiment, systems and methods are provided that including using a flushing device to flush medical devices, such as stent-grafts and/or their delivery systems.
Turning to the drawings,
The stent-graft 10 is loaded on the cannula 20 adjacent the distal tip 28 in a compressed or contracted condition and a cover or sleeve 30 is provided to maintain the stent-graft 10 in the constrained condition, as best seen in
Alternatively, the sleeve 30 may include one or more weakened regions (not shown) along which the filament 36 may extend such that the proximal end 38 of the filament 36 may be pulled to tear the weakened region(s) to release the sleeve 30 and allow deployment of the stent-graft 10. In one embodiment, the sleeve 30 may be attached to the stent-graft 10 at one or more locations, e.g., along a longitudinal line, such that the sleeve 30 remains attached to and/or partially around the stent-graft 10 but opens as the stent-graft 10 expands. Alternatively, the sleeve 30 may be separable from the stent-graft 10, and may remain coupled to the filament 36, which may be used to remove the released sleeve 30.
The pusher or stopper member 40 is an elongate tubular member including a proximal end 42 and a distal end 44 positioned adjacent the stent-graft 10 and sleeve 30. The pusher member 40 may include a lumen that receives the cannula 20, e.g., such that the pusher member 40 and cannula 20 are movable axially relative to one another. Alternatively, the pusher member 40 and cannula 20 may be axially fixed relative to one another or, in a further alternative, a fixed stop (not shown) may be attached to the cannula 20 adjacent the stent-graft 10 instead of the pusher member 40.
Optionally, a handle or hub (not shown) may be provided on the proximal end 22 of the cannula 20 including a port (also not shown) communicating with the lumen 26, e.g., including one or more seals, valves, and/or connectors, e.g., a female Luer lock fitting, to allow a source of fluid to be coupled to the port, e.g., for flushing the lumen 26, and/or to accommodate receiving a guidewire or other instrument (not shown) through the lumen 26. The hub may include one or more actuators or features, as desired for deploying the stent-graft 10. For example, the hub may include a side port (not shown) and the proximal end 38 of the filament 36 may pass through the side port such that a user may pull the proximal end 38 to release the sleeve 30. Alternatively, the proximal end 38 may be coupled to an actuator on the hub such that the actuator may be manipulated to pull the filament 36 and open the sleeve 30.
For example, during use, the introducing assembly 8 (carrying the stent-graft 10 constrained by the sleeve 30) may be introduced into a patient's body, e.g., from a percutaneous entry site, and advanced to a target location, e.g., within the patient's aorta, which is the site of an aneurysm (not shown). In an exemplary method, a guidewire may be introduced from the entry site and manipulated to position the guidewire adjacent the target location. An introducer sheath may be advanced over the guidewire and also positioned at the target location, whereupon the guidewire may be backloaded through the lumen 26 of the cannula 20, e.g., via opening 29 in the distal tip 28, and then the introducing assembly 8 may be advanced over the guidewire through the introducer sheath. Once properly positioned, the distal end 24 of the cannula 20 carrying the sleeve 30 and the stent-graft 10 may be exposed from the introducer sheath at the target site, and then the sleeve 30 opened to expose the stent-graft 10, e.g., by pulling the filament 36.
The stent-graft 10 may be configured to resiliently expand within the target location automatically upon being exposed. Alternatively, the introducing assembly 8 may include a balloon or other expandable member (not shown) under the stent-graft 10, which may be inflated or otherwise manipulated to expand the stent-graft 10. In one embodiment, the sleeve 30 may remain at the target delivery site, e.g., captured between the stent-graft 10 and the surrounding vessel wall or other tissue. Alternatively, the sleeve 30 may be removed from around the stent-graft 10, e.g., withdrawn into the introducer sheath using the filament 36 or other feature (not shown).
Prior to introduction of the introducing assembly 8 and stent-graft 10 into the patient's body (e.g., via an introducer sheath), the systems and methods herein may be used to flush the stent-graft 10, e.g., to remove air or other gases. For example, turning to
The first end 82 may include a hub 92, which may be removably coupled to the first end 82, e.g., by one or more of an interference fit, cooperating connectors, adhesive, and the like, to provide a fluid-tight seal when coupled to the first end 82. For example, the hub 92 may be removed to load an introducing assembly 8 carrying a stent-graft 10 or other medical device into the chamber 86, whereupon the hub 92 may be reconnected to the first end 82 over the pusher member 40 to seal the chamber 86 with the stent-graft 10 therein, as shown in
The hub 92 may include one or more passages therethrough, e.g., passage 92a shown in
Alternatively, the hub 92 may be substantially permanently attached to the first end 82 and the passage 92a may be sized and/or otherwise configured to accommodate introducing the introducing assembly 8 and stent-graft 10 into the chamber 86. For example, as shown in
The second end 84 of the flushing device 80 may include an opening 94, which may be selectively opened and closed, e.g., to introduce the introducing assembly 8 and stent-graft 10, after flushing, into a delivery device (not shown), such as an introducer sheath 150, as shown in
Optionally, the second end 84 may include one or more seals to provide a fluid-tight seal, e.g., to prevent gases or other material passing through the opening 94 into the chamber 86. For example, the one or more seals may prevent gases or other materials from entering the chamber 86 while accommodating transfer of the introducing assembly 8 through the opening 94 into a delivery device. In an alternative embodiment, a removable cap or other seal (not shown) may be removably coupled to the nipple 84a to selectively open and close the opening 94. In another alternative, a stopcock or a sliding valve (also not shown) may be provided at the second end 84, which may be movable between open and closed positions to open and close the opening 94. In yet another alternative, a fluid-tight membrane (also not shown) may cover the opening 94, which may be penetrated or torn (e.g., including one or more perforations or weakened regions that fail upon encountering a threshold force, e.g., when the distal tip 28 is advanced into the opening 94 into contact with the membrane), e.g., when the introducing assembly 8 is directed through the opening 94 into a delivery device (not shown).
In yet another alternative, as shown in
With continued reference to
For example, as shown in
The flushing device tube 80 and hub 92 may be formed from substantially rigid material, e.g., glass, metal, plastic, or composite materials, e.g., that are gas-impermeable to prevent air or other external gases from passing into the chamber 86. Alternatively, the tube 80 may be formed from flexible, gas-impermeable material, e.g., to provide a flexible sleeve into which the stent-graft 10 may be loaded, flushed, and then transferred. For example,
Returning to
Alternatively, the hub 92 may remain on the first end 82, and the introducing assembly 8 may be introduced through the passage 92a and positioned within the chamber 86. Optionally, if the chamber 86 is sealed before the introducing assembly 8 is introduced, the chamber 86 may be prefilled with a desired gas or flushing fluid, e.g., such that the gas or flushing fluid permeates into the sleeve 30 and/or stent-graft 10 upon introduction into the chamber 86, which may enhance flushing the introducing assembly 8 and/or stent-graft 10.
The opening 94 at the second end 84 may be sealed or closed, as described above, and the ports 90 may be closed such that the chamber 86 is isolated from the external environment of the flushing device 80. One or more sources of flushing fluid and/or vacuum may be coupled to the ports 90, whereupon the stopcocks 91 may be opened to flush the chamber 86, with the introducing assembly 8 and stent-graft 10 therein, one or more times. For example, a source of carbon dioxide or bio-inert gas may be coupled to the first port 90a and a source of vacuum may be coupled to the second port 90b to create a circuit that introduces the gas into the first port 90a, flushes the introducing assembly 8, particularly the stent-graft 10 within the sleeve 30 to replace air or other gases with the flush gas, and evacuates the air and excess flushing fluid out the second port 90b. Such flushing may continue for sufficient time to ensure that the flush gas substantially replaces any air within the chamber 86 and stent-graft 10.
Thereafter, a source of PFC solution may be coupled to the first port 90a and used to flush the gas. In addition or alternatively, a source of saline may be coupled to the first port 90a and used to flush the PFC solution and/or the previously introduced gas. It will be appreciated that any sequence of flushing fluids and/or procedures may be used, such as those described in the Rohlffs et al. publication identified above, the entire disclosure of which is expressly incorporated by reference herein.
Alternatively, the port 90a may include multiple connectors (not shown) such that multiple sources may be connected at the same time, and the stopcock 91a may be selectively directed to different positions to allow a desired source to be delivered into the chamber 86. Thus, in this alternative, the stopcock 91a may be manually or mechanically switched between the different positions in any desired sequence to flush the chamber 86 and introducing assembly 8, e.g., corresponding to any of the methods described elsewhere herein.
In alternative embodiments, one or both of the ports 90 may be omitted and, instead, sources of flushing fluid and/or vacuum may be coupled to the opening 94 and/or passage 93 to provide a flushing circuit that may operate similarly to the methods just described. In addition or alternatively, a flushing machine (not shown) may be connected to the ports 90, which may be self-contained and/or may operate to introduce various flushing fluids and/or collect fluids once connected to the flushing device 80. For example, the machine may include multiple reservoirs containing different fluids, i.e., gases and/or liquids, that may be delivered into the chamber 86.
Once the introducing assembly 8 has been flushed, the introducing assembly 8 may be loaded into a delivery device, e.g., before or after introducing the delivery device into a patient's body. For example,
For example, a guidewire or other rail 158 may already be positioned through the lumen 156 of the introducer sheath 150, e.g., used to introduce and/or guide the introducer sheath 150 through the patient's vasculature from a peripheral access site to a target location within the patient's body (not shown). The guidewire 158 may be backloaded through the opening 29 in the distal tip 28 and through the lumen 26 of the cannula 20 to facilitate guiding the introducing assembly 8 into the lumen 156. For example, the introducing assembly 8 may be advanced to slide the distal tip 28 through the opening 94, thereby maintaining a substantially fluid-tight seal to further prevent exposure of the introducing assembly 8 and stent-graft 10 to gases or the external environment. Once the distal tip 28, stent-graft 10, and the other components of the introducing assembly 8 enter the lumen 156 of the introducer sheath 150, the introducer assembly 8 may be advanced through the lumen 156, e.g., into a distal end of the introducer sheath 150, e.g., already positioned at the target location. The flushing device 80 may then be removed from the hub 150 and, optionally, torn or otherwise separated if the flushing device 80 includes weakened regions, similar to the flushing device 280 shown in
For example, as shown in
Once the introducing assembly 8 and stent-graft 10 are properly positioned at the target location, the hub 152 may be withdrawn proximally to expose and/or deploy the stent-graft 10, as described elsewhere herein.
Turning to
However, unlike previous embodiments, the flushing device 180 includes annular chambers 187 surrounding the central chamber 186 (into which a stent-graft 10 and/or introducing device 110 is introduced). As can be seen, the ports 190 communicate directly with the annular chambers 187, and the annular chambers 187 communicate with the central chamber 186 via openings 189. The openings 189 are positioned at opposite ends of the flushing device 180, e.g., with a first opening 189a located immediate adjacent the end opening 194 and the second opening 189b located immediately adjacent the hub 192.
This configuration may facilitate introducing one or more flushing fluids to displace air or other gases within the chamber 186 and stent-graft 10 during flushing. For example, when a flushing fluid is introduced via the first port 190a, the fluid may initially fill the first annular chamber 187a and then enter the central chamber 186 via the first opening 189a. The flushing fluid will then be forced through the central chamber 186 along the flushing device 180 from the second end 184 towards the first 182, creating a desired pressure within the chamber 186 that may facilitate removing trapped gases within the stent-graft 10 and/or the introducing assembly 8. After reaching the first end 182, the fluid may exit the second opening 189b into the second annular chamber 187b, which may fill until the fluid is directed into the second port 190b, e.g., under vacuum from a source of vacuum or simply under the positive pressure within the chamber 186 into a container.
For example, as shown in
In another alternative, the flushing chamber and one or more ports may be provided within a hub of a delivery device, rather than as a separate device. For example, in this alternative, one or more sources of flushing fluid and/or vacuum may be coupled to the port(s) of the hub to flush the chamber and stent-graft. Once flushing is completed, the stent-graft may be advanced from the chamber through a lumen of the delivery device, similar to other embodiments herein.
While the invention is susceptible to various modifications, and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but to the contrary, the invention is to cover all modifications, equivalents and alternatives falling within the scope of the appended claims.
The present application claims benefit of co-pending provisional application Ser. No. 62/247,287, filed Oct. 28, 2015, the entire disclosure of which is expressly incorporated by reference herein.
Number | Date | Country | |
---|---|---|---|
62247287 | Oct 2015 | US |